https://www.selleckchem.com/pr....oducts/BMS-790052.ht
37, 95% CI 1.18-1.60, p = 0.00, and renal function impairment (OR 2.61, 95% CI 1.78-3.81, p = 0.00 than young patients, and there was a opposite result in genital mycotic infections (OR 0.69, 95% CI 0.55-0.87, p = 0.002). No significant differences were recorded in the reduction of fasting blood glucose, blood pressure, body weight, and in incidence of overall AEs and fracture. In summary, relatively satisfying efficacy was observed in the elderly patients receiving SGLT2i. Although some AEs were more prevalent among older patien